Vimarsana
Biggest News Aggregation in the World

Page 2 - Test Performance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Test Performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Test Performance Today - Breaking & Trending Today

Latest Insights from the PATHFINDER Study: Cancer Detection Advancements - Vimarsana News

Latest Insights from the PATHFINDER Study: Cancer Detection Advancements

Panelists explore recent findings of the PATHFINDER study, focusing on the objectives, study design, key results, and differences from previous studies, shedding light on the potential of early cancer detection tests.

Naturals to Lead Cosmetic Preservative Growth to US $562M Despite Their Cost - Vimarsana News

Naturals to Lead Cosmetic Preservative Growth to US $562M Despite Their Cost

Two market analysts have projected that cosmetic preservatives will surpass $562 million - one says by 2027, the other by 2028. While natural and organic options are preferred, the costs of these solutions pose challenges.

CNN Anderson Cooper 360 January 4, 2022 01:02:00 - Vimarsana News

CNN Anderson Cooper 360 January 4, 2022 01:02:00

They are very good when they are given sequentially but as a single test, they are not as sensitive. >> reporter: adding to the confusion? a statement from abbott -- the company that makes one of the authorized at-home tests binax now. binax now detected the virus in all tests an equivalent sensitivity as other variants and data from customers has not shown any change in test performance. still, the cdc isn't recommending any rapid tests as proof someone is covid free after isolation. >> we actually don't know how our rapid tests perform, and how well they predict whether you are transmissible...

CNN Anderson Cooper 360 January 4, 2022 05:02:00 - Vimarsana News

CNN Anderson Cooper 360 January 4, 2022 05:02:00

The fda has announced that rapid-antigen tests may be less sensitive to picking up the omicron variant. meaning, they will spot an infection less often. pcr tests are considered the gold standard. but the fda still suggests people should continue to use rapid tests, so do they work? >> the answer is they do. they are very good when they are given sequentially but as a single test, they are not as sensitive. >> reporter: adding to the confusion? a statement from abbott -- the company that makes one of the authorized at-home tests binax now. binax now detected the virus in all tests an equivalen...

CNN Early Start With Christine Romans and Laura Jarrett December 29, 2021 10:02:00 - Vimarsana News

CNN Early Start With Christine Romans and Laura Jarrett December 29, 2021 10:02:00

That could send more people out for pcr tests, extending already very long lines. but dr. anthony fauci still says do not pass up the rapid tests. >> the tests are still worthwhile. don't let anybody think that the fda was saying the tests are no longer good. they're saying they're less sensitive now. they never were 100% sensitive. some of the tests have a diminution further of the sensitivity, but they still say the tests are useful and should be used. >> abbott, the company that makes the popular test tells cnn it has not seen a change in the test performance. >> so we are seeing this explo...